流式细胞技术市场规模、份额、成长分析（按技术、产品、应用、最终用户和地区）- 2025 年至 2032 年产业预测

预计 2023 年全球流式细胞技术市场规模将达到 61 亿美元，并从 2024 年的 66.9 亿美元增长到 2032 年的 139.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 9.6%。

由于癌症、免疫疾病和感染疾病的发生率不断上升，流式细胞技术市场预计将经历显着增长。生物技术、生命科学和生物製药领域不断增加的研发投入正在推动对流式细胞技术仪的需求。技术进步，例如用于照护现场检验（POC）的微流体流式细胞技术的出现，正在提高这些仪器的分析能力。例如，这些创新测试利用流式细胞技术提供对患者对 COVID-19 抗原的反应的关键见解，从而有助于做出明智的治疗决策。随着全球感染疾病疫情持续上升，流式细胞技术技术的采用预计将成长，进一步促进未来几年的产业发展动能。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 专利分析
• 监管分析
• 技术分析
• 使用案例

流式细胞技术市场规模（依技术及复合年增长率） (2025-2032)

• 市场概览
• 基于细胞的流式细胞技术
• 以微珠为基础的流式细胞技术

流式细胞技术市场规模（按产品和复合年增长率） (2025-2032)

• 市场概览
• 试剂和耗材
  • 抗体
  • 检测方法和套件
  • 其他试剂和耗材
• 装置
  • 细胞分析仪
  • 高量程细胞分析仪
  • 中阶细胞分析仪
  • 低量程细胞分析仪
  • 细胞分选装置
  • 高范围细胞分选器
  • 中阶细胞分选仪
  • 低量程细胞分选仪
• 服务
• 软体
• 配件

流式细胞技术市场规模（依应用）及复合年增长率（2025-2032）

• 市场概览
• 研究用途
  • 製药和生物技术
  • 药物研发
  • 干细胞研究
  • 管内毒性测试
  • 免疫学
  • 细胞分选
  • 细胞凋亡
  • 细胞週期分析
  • 细胞活力
  • 细胞计数
  • 其他研究应用
• 临床应用
  • 癌症诊断
  • 血液学
  • 自体免疫疾病
  • 器官移植
  • 其他临床应用
• 工业应用

流式细胞技术市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 学术研究所
• 医院和临床实验室
• 製药和生物技术公司

流式细胞技术市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

    主要企业简介

    • 碧迪公司（美国）
    • 丹纳赫公司（美国）
    • 赛默飞世尔科技公司（美国）
    • 安捷伦科技公司（美国）
    • 索尼集团公司（日本）
    • Bio-Rad Laboratories, Inc.（美国）
    • Miltenyi BIoTec GmbH（德国）
    • Enzo Biochem公司（美国）
    • Sysmex株式会社（日本）
    • bioMErieux SA（法国）
    • Cytonome, LLC（美国）
    • 赛多利斯股份公司（德国）
    • Cytek Biosciences, Inc.（美国）
    • Apogee Flow Systems Ltd.（英国）
    • 默克集团（德国）
    • 贝克曼库尔特公司（美国）
    • Stratedigm公司（美国）
    • Nanocellect Biomedical（美国）

结论和建议

Global Flow Cytometry Market size was valued at USD 6.1 billion in 2023 and is poised to grow from USD 6.69 billion in 2024 to USD 13.92 billion by 2032, growing at a CAGR of 9.6% during the forecast period (2025-2032).

The flow cytometry market is poised for significant growth, driven by the increasing incidence of cancer, immune disorders, and infectious diseases. Rising R&D investments in biotechnology, life sciences, and biopharmaceutical sectors are fueling the demand for flow cytometry instruments. Technological advancements, such as the emergence of microfluidic flow cytometry for Point-of-Care (POC) testing, are enhancing the analytical capabilities of these instruments. For instance, these innovative tests utilize flow cytometry to provide critical insights into patients' responses to COVID-19 antigens, facilitating informed treatment decisions. As the prevalence of infectious diseases continues to rise globally, the adoption of flow cytometry techniques is expected to expand, further contributing to industry momentum in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Flow Cytometry market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Flow Cytometry Market Segments Analysis

Global Flow Cytometry Market is segmented by Technology, Product, Application, End User and region. Based on Technology, the market is segmented into Cell-Based Flow Cytometry and Bead-Based Flow Cytometry. Based on Product, the market is segmented into Reagents & Consumables, Instruments, Services, Software and Accessories. Based on Application, the market is segmented into Research Applications, Clinical Applications and Industrial Applications. Based on End User, the market is segmented into Academic & Research Institutes, Hospitals & Clinical Testing Laboratories and Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Flow Cytometry Market

The rising focus on personalized medicine and targeted therapies is significantly boosting the demand for advanced flow cytometry techniques. Flow cytometry's capability to simultaneously analyze multiple parameters enhances the precise characterization of cells, which is essential in formulating individualized treatment strategies. This technology allows for a deeper understanding of cellular properties and behaviors, making it an invaluable tool in the development of tailored therapeutic approaches. As healthcare increasingly prioritizes personalized treatment options, the role of flow cytometry in accurately assessing and monitoring patient conditions will continue to expand, thereby driving growth in the market.

Restraints in the Flow Cytometry Market

The flow cytometry market faces significant constraints due to the high initial investment and ongoing maintenance costs associated with the equipment. These financial barriers can be a deterrent for many laboratories and institutions, particularly smaller or underfunded facilities that may struggle to allocate sufficient resources for such advanced technology. As a result, the reluctance or inability to invest in flow cytometry can hinder its adoption and integration into various research and clinical settings. Consequently, this financial challenge may limit the overall growth potential of the flow cytometry market, impacting its accessibility and utilization across the healthcare and research sectors.

Market Trends of the Flow Cytometry Market

The flow cytometry market is witnessing a transformative phase, significantly influenced by advancements in cell sorting technologies that enhance the ability to isolate and analyze individual cell populations. This is particularly impactful in critical fields such as cancer research, immunology, and stem cell research, where high purity and accuracy are paramount. The increasing demand for precise cellular analysis in both research and clinical environments is propelling market growth, highlighting the pivotal role of flow cytometry in personalized medicine and targeted therapies. As researchers and clinicians seek innovative solutions to unravel complex cellular behaviors, the flow cytometry market is poised for sustained expansion and innovation.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies

Global Flow Cytometry Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Cell-Based Flow Cytometry
• Bead-Based Flow Cytometry

Global Flow Cytometry Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Reagents & Consumables
  • Antibodies
  • Assays & Kits
  • Other Reagents & Consumables
• Instruments
  • Cell Analyzers
  • High-range cell analyzers
  • Mid-range cell analyzers
  • Low-range cell analyzers
  • Cell Sorters
  • High-range cell sorters
  • Mid-range cell sorters
  • Low-range cell sorters
• Services
• Software
• Accessories

Global Flow Cytometry Market Size by Application & CAGR (2025-2032)

• Market Overview
• Research Applications
  • Pharmaceutical & Biotechnology
  • Drug Discovery
  • Stem Cell Research
  • In Vitro Toxicity Testing
  • Immunology
  • Cell Sorting
  • Apoptosis
  • Cell Cycle Analysis
  • Cell Viability
  • Cell Counting
  • Other Research Applications
• Clinical Applications
  • Cancer Diagnostics
  • Hematology
  • Autoimmune Diseases
  • Organ Transplantation
  • Other Clinical Applications
• Industrial Applications

Global Flow Cytometry Market Size by End User & CAGR (2025-2032)

• Market Overview
• Academic & Research Institutes
• Hospitals & Clinical Testing Laboratories
• Pharmaceutical & Biotechnology Companies

Global Flow Cytometry Market Size & CAGR (2025-2032)

• North America (Technology, Product & Service, Application, End User)
  • US
  • Canada
• Europe (Technology, Product & Service, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product & Service, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product & Service, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product & Service, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Becton, Dickinson, and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sony Group Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzo Biochem, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMErieux S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytonome, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytek Biosciences, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apogee Flow Systems Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stratedigm, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nanocellect Biomedical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations